Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 2Melanoma 2Solid Tumors 1Skin Neoplasms 1Leukemia, Lymphoid 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Bronchiolitis Obliterans Syndrome 1

Interventions

tofacitinib 7ibrutinib 6ruxolitinib 3ofatumumab 3asciminib 3Imatinib Mesylate 3Dasatinib 3nilotinib 2bosutinib 2Rituximab 2Oxycodone 2Naloxone 2KW-2478 2sodium luminolate 1oblimersen 1obinutuzumab 1mocetinostat 1milatuzumab 1ixekizumab 1fenebrutinib 1canakinumab 1belumosudil 1baricitinib 1axatilimab 1abexinostat 1Vision, Ocular 1Sofosbuvir 1Sirolimus 1Saline Solution 1Ribavirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Bronchiolitis Obliterans Syndrome × oblimersen × Clear all
NCT00021749 2009-11-13

Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia

Genta Incorporated

Phase 1/2 Completed
40 enrolled
LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡